- Report
- July 2026
- 110 Pages
Global
From €4467EUR$4,750USD£3,727GBP
- Report
- June 2026
- 147 Pages
Global
From €3761EUR$3,999USD£3,137GBP
- Report
- September 2026
- 32 Pages
Global
From €2774EUR$2,950USD£2,314GBP
- Report
- August 2026
- 38 Pages
Global
From €2774EUR$2,950USD£2,314GBP
- Report
- December 2025
- 150 Pages
Global
From €4561EUR$4,850USD£3,805GBP
- Report
- November 2026
- 160 Pages
Global
From €3122EUR$3,320USD£2,605GBP
€3903EUR$4,150USD£3,256GBP
- Report
- November 2026
- 160 Pages
Global
From €3122EUR$3,320USD£2,605GBP
€3903EUR$4,150USD£3,256GBP
- Report
- June 2026
- 100 Pages
North America
From €4467EUR$4,750USD£3,727GBP
- Report
- September 2025
- 327 Pages
Global
From €3947EUR$4,197USD£3,293GBP
- Report
- March 2023
- 232 Pages
Global
From €4901EUR$5,393USD£3,950GBP
- Report
- September 2023
- 310 Pages
Global
From €4901EUR$5,393USD£3,950GBP
- Report
- January 2020
- 508 Pages
Global
From €4608EUR$4,899USD£3,844GBP
- Report
- June 2024
- 295 Pages
Global
From €4655EUR$4,950USD£3,884GBP
- Report
- March 2023
- 139 Pages
Global
From €2351EUR$2,500USD£1,961GBP
- Report
- December 2021
- 206 Pages
Global
From €5173EUR$5,500USD£4,315GBP
- Report
- June 2022
- 207 Pages
Global
From €2469EUR$2,625USD£2,059GBP
€4938EUR$5,250USD£4,119GBP
- Report
- July 2024
- 120 Pages
Global
From €5596EUR$5,950USD£4,668GBP
- Report
- October 2023
- 200 Pages
Global
From €5596EUR$5,950USD£4,668GBP
- Report
- May 2024
- 166 Pages
Global
From €2351EUR$2,500USD£1,961GBP
- Report
- August 2025
- 180 Pages
Global
From €4232EUR$4,500USD£3,531GBP

The Cell Therapeutic market is a subset of the biopharmaceutical industry, focusing on the development and commercialization of cell-based therapies. These therapies involve the use of living cells, either from the patient or from a donor, to treat a variety of diseases. Cell therapies can be used to replace or repair damaged cells, to stimulate the body's own immune system to fight disease, or to deliver drugs directly to the site of a disease. Cell therapies are being developed for a wide range of diseases, including cancer, autoimmune diseases, and genetic disorders.
Cell therapies are often complex and expensive to develop, and require specialized manufacturing processes. As a result, the Cell Therapeutic market is highly regulated, with stringent safety and efficacy requirements.
Some companies in the Cell Therapeutic market include Kite Pharma, Juno Therapeutics, and Bluebird Bio. Show Less Read more